Lubiprostone

In the US, Lubiprostone (lubiprostone systemic) is a member of the drug class chloride channel activators and is used to treat Constipation - Chronic and Irritable Bowel Syndrome.

US matches:

• Lubiprostone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A06AX03

CAS registry number (Chemical Abstracts Service)

0333963-40-9

Chemical Formula

C20-H32-F2-O5

Molecular Weight

390

Therapeutic Category

Prostaglandin analogue

Chemical Names

(-)-7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptanoic acid (WHO)

7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptansäure (IUPAC)

Prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11α)- (USAN)

Foreign Names

• Lubiprostonum (Latin)
• Lubiproston (German)
• Lubiprostone (French)
• Lubiprostona (Spanish)

Generic Names

• Lubiprostone (OS: USAN)
• RU-0211 (IS: RTechUeno)
• SPI-0211 (IS: Sucampo)

Brand Names

• Amitiza
  Sucampo, United States; Sucampo Pharma, Switzerland; Takeda, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.